ArticleInternational journal of women's health2010
Raising HDL cholesterol in women.
Article in International journal of women's health, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Effect of a low-fat or low-carbohydrate weight-loss diet on markers of cardiovascular risk among premenopausal women: a randomized trial.Journal of women's health (2002) · 2014Trial
- Reversal for metabolic syndrome criteria following the CHANGE program: What are the driving forces? Results from an intervention community-based study.AIMS public health · 2025Article
- Article
- Correlates of normal and decreased HDL cholesterol levels in type 2 diabetes: a cohort-based cross-sectional study.Lipids in health and disease · 2024Article
- Article
- Critical assessment of the metabolic syndrome definitions in the adult general population of the United States - the Multi-Ethnic Study of Atherosclerosis (MESA).Journal of diabetes and metabolic disorders · 2023Article
- Early Midlife Cardiovascular Health Influences Future HDL Metrics in Women: The SWAN HDL Study.Journal of the American Heart Association · 2022Article
- Associations of Abdominal and Cardiovascular Adipose Tissue Depots With HDL Metrics in Midlife Women: the SWAN Study.The Journal of clinical endocrinology and metabolism · 2022Article
- HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study.The Journal of clinical endocrinology and metabolism · 2021Article
- Electrophysiologic severity of carpal tunnel syndrome in diabetic patients of the Saudi population.Neurosciences (Riyadh, Saudi Arabia) · 2019Article
- Haematological parameters and lipid profile abnormalities among patients with Type-2 diabetes mellitus in Ghana.Lipids in health and disease · 2018Article
- Relationship Between Glycated Haemoglobin and Carotid Atherosclerotic Disease Among Patients with Acute Ischaemic Stroke.Sultan Qaboos University medical journal · 2018Article
- HDL and associated factors stratified by sex and menopausal status: results from a community-based survey in Taiwan.Oncotarget · 2018Article
- Prevalence of Metabolic Syndrome and Its Individual Components Among Midwestern University Students.Journal of community health · 2017Article
- CD36 haplotypes are associated with lipid profile in normal-weight subjects.Lipids in health and disease · 2013Article
- The effect of quitting smoking on HDL-cholesterol - a review based on within-subject changes.Biomarker research · 2013Article
- Markers of increased cardiovascular risk in postmenopausal women: focus on oxidized-LDL and HDL subpopulations.Disease markers · 2013Article
- Serum lipid profile of newly diagnosed hypertensive patients in nnewi, South-East Nigeria.International journal of hypertension · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High-density lipoprotein cholesterol (HDL-C) concentration is essential in the determination of coronary heart disease (CHD) risk in women. This is especially true in the postmenopausal state, where lipid profiles and CHD risk mimic that of age-matched men. Thus, interventions designed to reduce CHD risk by raising HDL-C levels may have particular significance during the transition to menopause. This review discusses HDL-C-raising therapies and the role of HDL in the primary prevention of CHD in women. Lifestyle-based interventions such as dietary change, aerobic exercise regimens, and smoking cessation are initial steps that are effective in raising HDL-C, and available data suggest women respond similarly to men with these interventions. When combined with pharmacotherapy, the effects of these lifestyle alterations are further amplified. Though studies demonstrating gender-specific differences in therapy are limited, niacin continues to be the most effective agent in raising HDL-C levels, especially when used in combination with fibrate or statin therapy. Emerging treatments such as HDL mimetic therapy show much promise in further raising HDL-C levels and improving cardiovascular outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.